Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An intrahepatic cholangiocarcinoma characterized by the presence of signet ring adenocarcinoma cells.
Biomarker and diagnostic research for signet ring cell intrahepatic cholangiocarcinoma has been reported in the published literature.
No clinical trials have been registered for signet ring cell intrahepatic cholangiocarcinoma.
6 publications have been identified in PubMed for signet ring cell intrahepatic cholangiocarcinoma. Research spans Case Report / Case Series (67%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Torres S (2026). [PMID: 40850903](https://pubmed.ncbi.nlm.nih.gov/40850903/). *J Am Soc Cytopathol*. [Review / Meta-Analysis]
Navinés-López J (2026). [PMID: 41397636](https://pubmed.ncbi.nlm.nih.gov/41397636/). *Cir Esp (Engl Ed)*. [Case Report / Case Series]
Liang Z (2026). [PMID: 39831606](https://pubmed.ncbi.nlm.nih.gov/39831606/). *Rev Esp Enferm Dig*. [Case Report / Case Series]
Wen Y (2025). [PMID: 41158219](https://pubmed.ncbi.nlm.nih.gov/41158219/). *Transl Cancer Res*. [Diagnostic / Biomarker]
Naito Z (2025). [PMID: 40352962](https://pubmed.ncbi.nlm.nih.gov/40352962/). *Surg Case Rep*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 2:07 PM UTC